Getein Biotech, Inc reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,377.17 million compared to CNY 922.16 million a year ago. Revenue was CNY 1,377.17 million compared to CNY 922.16 million a year ago.

Net income was CNY 475.2 million compared to CNY 253.12 million a year ago. Basic earnings per share from continuing operations was CNY 0.93 compared to CNY 0.5 a year ago. Diluted earnings per share from continuing operations was CNY 0.93 compared to CNY 0.5 a year ago.